Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
If You Were Big, You Probably Got Bigger. More details...
CBT 200 Gains 43 Points Or 1.1%. More details...
More Biotechs Lay Out Future Plans. More details...
CBT 200 Drops .66%. More details...
Including Private and Public Companies. More details...
CBT 200 Rises 33 Points. More details...
CBT 200 Drops 19 Points. More details...
CBT 200 Slips 35 Points Lower. More details...
Viral Therapy Is Coming Of Age. More details...
CBT 200 Runs Up Another 1%. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
